Factors identified for increased post-surgery weight gain among breast cancer survivors
the ONA take:
According to a new study published in the journal BMC Cancer, researchers have found that average long-term weight gain among breast cancer survivors is small, but certain subgroups of women experience greater weight gain associated with adverse health.
For the study, researchers sought to investigate body weight changes following breast cancer over 6 years and whether weight changes are linked with behavioral, diagnostic, personal, or treatment characteristics. Researchers identified 287 Australian women diagnosed with early-stage invasive breast cancer.
Results showed that 57% of women were overweight or obese at 6 months post-surgery, which increased to 68% at 72 months post-surgery. Researchers found that 24% of participants experienced clinically significant weight gain between 6 and 18 months and 39% experienced clinically significant weight gain between 6 and 72 months post-surgery.
In addition, researchers found that more extensive lymph node removal, receiving radiation therapy, being treated on the non-dominant side, and decreased physical activity levels at 6 months post-surgery were associated with higher body weights after breast cancer.
The findings suggest that healthy weight education should be integrated into breast cancer care to improve the quality of cancer survivorship.
Average long-term weight gain among breast cancer survivors is small, but certain subgroups experience greater gain associated with adverse health.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Risk for Cardiovascular Disease Higher in Survivors of Testicular Cancer
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|